KURA ONCOLOGY, INC. Derivative, Gain (Loss) on Derivative, Net
KURA ONCOLOGY, INC. (KURA) reported Derivative, Gain (Loss) on Derivative, Net of -$268.00 thousand for the 12-month period ending 2015-12-31, per its 10-K filed 2017-03-14.
Discontinued › Income Statement › Other Income
us-gaap:DerivativeGainLossOnDerivativeNet · last filed 2017-03-14
- KURA ONCOLOGY, INC. derivative, gain (loss) on derivative, net for the quarter ending 2015-12-31 was $0.00.
- KURA ONCOLOGY, INC. derivative, gain (loss) on derivative, net for the quarter ending 2015-09-30 was -$39.00K.
- KURA ONCOLOGY, INC. derivative, gain (loss) on derivative, net for the quarter ending 2015-06-30 was -$210.00K.
- KURA ONCOLOGY, INC. derivative, gain (loss) on derivative, net for the quarter ending 2015-03-31 was $97.00K.
- KURA ONCOLOGY, INC. derivative, gain (loss) on derivative, net for fiscal 2015 was -$268.00K.
| Period end | Derivative, Gain (Loss) on Derivative, Net 3 month | Derivative, Gain (Loss) on Derivative, Net 6 month | Derivative, Gain (Loss) on Derivative, Net 9 month | Derivative, Gain (Loss) on Derivative, Net 9 month as first filed | Derivative, Gain (Loss) on Derivative, Net 12 month |
|---|---|---|---|---|---|
| 2015-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-14 | -$39.00K derived: sum of 2 quarters · filed 2017-03-14 | -$249.00K derived: sum of 3 quarters · filed 2017-03-14 | -$268.00K 10-K · filed 2017-03-14 | |
| 2015-09-30 | -$39.00K 10-Q · filed 2015-11-13 | -$249.00K derived: sum of 2 quarters · filed 2015-11-13 | -$268.00K 10-Q · filed 2016-11-07 | $268.00K 10-Q · filed 2015-11-13 | |
| 2015-06-30 | -$210.00K 10-Q · filed 2015-08-14 | -$307.00K 10-Q · filed 2016-08-10 | |||
| 2015-03-31 | $97.00K 10-Q · filed 2015-05-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Arbutus Biopharma Corp (ABUS) | $0.965B | 6.19 | |
| Corvus Pharmaceuticals, Inc. (CRVS) | United States | $0.994B | -23.25 |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| Pacira BioSciences, Inc. (PCRX) | United States | $1.020B | 69.03 |
| MoonLake Immunotherapeutics (MLTX) | Switzerland | $1.031B | -5.43 |
| Apnimed, Inc. (APMD) | United States | $0.899B | |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |
| Savara Inc (SVRA) | United States | $1.044B | -9.10 |
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 |